Niagen Bioscience, Inc. (NAGE)
6.52
-0.11
(-1.66%)
USD |
NASDAQ |
Dec 12, 16:00
6.53
+0.01
(+0.15%)
After-Hours: 20:00
Niagen Bioscience EPS Diluted (Quarterly): 0.0528 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| TransMedics Group, Inc. | 0.6601 |
| Liquidia Corp. | -0.0409 |
| Recursion Pharmaceuticals, Inc. | -0.363 |
| Caris Life Sciences, Inc. | 0.0862 |
| CEL-SCI Corp. | -1.365 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 4.578M |
| Revenue (Quarterly) | 33.99M |
| Total Expenses (Quarterly) | 29.41M |
| Enterprise Value | 459.10M |
| Gross Profit Margin (Quarterly) | 64.52% |
| Profit Margin (Quarterly) | 13.47% |
| Earnings Yield | 3.73% |
| Operating Earnings Yield | 3.51% |
| Normalized Earnings Yield | 3.733 |